Wyeth Korea to launch Enbrel at year-end

Wyeth Korea announced the Korea Food and Drug Administration has recently approved Enbrel (entanercept), TNF (tumor necrosis factor) inhibitor for the treatment of rheumatoid arthritis drug, as local trials last March was successfully completed in patients with rheumatoid arthritis.

Enbrel implies a drug that may enable refurbish a new energy in patients suffering from pain.

Since its fir...